Literature DB >> 11344173

Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11344173     DOI： 10.1210/jcem.86.5.7471

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  32 in total

Review 1.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Problems with GH doping in sports.

Authors:  M Bidlingmaier; Z Wu; C J Strasburger
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 3.  Maternal nutrition, fetal weight, body composition and disease in later life.

Authors:  Z Zadik
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 4.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 5.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 6.  The GH/IGF-1 system in critical illness.

Authors:  Itoro E Elijah; Ludwik K Branski; Celeste C Finnerty; David N Herndon
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-10       Impact factor: 4.690

7.  Limb lengthening in children with Russell-Silver syndrome: a comparison to other etiologies.

Authors:  V Goldman; T H McCoy; M D Harbison; A T Fragomen; S R Rozbruch
Journal:  J Child Orthop       Date:  2013-01-05       Impact factor: 1.548

8.  Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress.

Authors:  V Popovic; S Pekic; D Pavlovic; N Maric; M Jasovic-Gasic; B Djurovic; M Medic Stojanoska; V Zivkovic; M Stojanovic; M Doknic; N Milic; M Djurovic; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 9.  Small for gestational age: towards 2004.

Authors:  Z Zadik; O Dimant; A Zung; R Reifen
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

10.  Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin).

Authors:  Dana S Hardin
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.